vTv Therapeutics (5VT0) Ratios
vTv Therapeutics Ratios
DE:5VT0's free cash flow for Q2 2026 was $-11.44M. For the 2026 fiscal year, DE:5VT0's free cash flow was increased by $0.00 and operating cash flow was $-11.44M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 13.54 | 7.34 | 1.00 | 3.52 | 1.84 |
| Quick Ratio | 13.54 | 7.34 | 1.00 | 3.52 | 1.83 |
| Cash Ratio | 13.39 | 7.07 | 0.89 | 1.57 | 1.58 |
| Solvency Ratio | -1.06 | -0.77 | -0.68 | -0.70 | -1.26 |
| Operating Cash Flow Ratio | -3.80 | -4.87 | -1.80 | -1.98 | -2.27 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -99.90 | -68.06 | -75.42 |
| Net Current Asset Value | $ 64.43M | $ 14.15M | $ -18.91M | $ -305.00K | $ 5.37M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.05 | 0.02 | 0.04 |
| Debt-to-Equity Ratio | 0.00 | 0.01 | -0.02 | -0.07 | -0.10 |
| Debt-to-Capital Ratio | 0.00 | 0.01 | -0.02 | -0.07 | -0.11 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.40 | 3.14 | -0.45 | -3.09 | -2.62 |
| Debt Service Coverage Ratio | -5176.33 | 0.00 | -126.78 | -104.46 | -65.78 |
| Interest Coverage Ratio | -5468.00 | 0.00 | -1961.69 | -1502.67 | -1805.17 |
| Debt to Market Cap | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.03 | 0.26 | 0.38 | 0.60 |
| Net Debt to EBITDA | 2.86 | 1.62 | 0.34 | 0.46 | 0.71 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 100.00% | 0.00% | 100.00% | 100.00% |
| EBIT Margin | 0.00% | -2222.71% | 0.00% | -1231.81% | -439.55% |
| EBITDA Margin | 0.00% | -2213.96% | 0.00% | -1227.25% | -437.33% |
| Operating Profit Margin | 0.00% | -2377.58% | 0.00% | -1116.95% | -540.87% |
| Pretax Profit Margin | 0.00% | -2222.71% | 0.00% | -1232.56% | -439.85% |
| Net Profit Margin | 0.00% | -1815.34% | 0.00% | -949.65% | -324.27% |
| Continuous Operations Profit Margin | 0.00% | -2232.55% | 0.00% | -1242.47% | -442.72% |
| Net Income Per EBT | 86.79% | 81.67% | 77.99% | 77.05% | 73.72% |
| EBT Per EBIT | 94.73% | 93.49% | 101.82% | 110.35% | 81.32% |
| Return on Assets (ROA) | -30.00% | -48.25% | -183.79% | -57.66% | -50.98% |
| Return on Equity (ROE) | -41.86% | -151.34% | 82.05% | 178.44% | 133.34% |
| Return on Capital Employed (ROCE) | -39.41% | -73.12% | -6391.48% | -88.29% | -127.60% |
| Return on Invested Capital (ROIC) | -39.41% | -72.75% | -3359.95% | -87.00% | -124.38% |
| Return on Tangible Assets | -30.00% | -48.25% | -183.79% | -57.66% | -50.98% |
| Earnings Yield | -8.01% | -23.16% | -84.46% | -37.64% | -20.83% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 16.40 | 0.00 | 0.16 | 70.26 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 6.65 | 0.00 | 3.63 | 5.89 |
| Asset Turnover | 0.00 | 0.03 | 0.00 | 0.06 | 0.16 |
| Working Capital Turnover Ratio | 0.00 | 0.06 | 0.00 | 0.15 | 1.01 |
| Cash Conversion Cycle | 0.00 | 22.25 | 0.00 | 2245.71 | 5.19 |
| Days of Sales Outstanding | 0.00 | 22.25 | 0.00 | 2245.71 | 5.19 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 22.25 | 0.00 | 2245.71 | 5.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -3.00 | -4.39 | -9.15 | -7.94 | -12.33 |
| Free Cash Flow Per Share | -3.00 | -4.39 | -9.15 | -7.95 | -12.33 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | -726.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | -726.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | -149.75 | -36.07 | -21.29 | -20.72 |
| Operating Cash Flow to Sales Ratio | 0.00 | -24.88 | 0.00 | -7.56 | -4.82 |
| Free Cash Flow Yield | -7.50% | -31.75% | -79.58% | -29.99% | -30.97% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -12.50 | -4.32 | -1.18 | -2.66 | -4.80 |
| Price-to-Sales (P/S) Ratio | 0.00 | 78.37 | 0.00 | 25.23 | 15.56 |
| Price-to-Book (P/B) Ratio | 5.23 | 6.53 | -0.97 | -4.74 | -6.40 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.34 | -3.15 | -1.26 | -3.33 | -3.23 |
| Price-to-Operating Cash Flow Ratio | -13.34 | -3.15 | -1.26 | -3.34 | -3.23 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.06 | 0.44 | -0.13 | -0.32 |
| Enterprise Value Multiple | -7.98 | -1.92 | -0.58 | -1.60 | -2.85 |
| Enterprise Value | 247.93M | 43.12M | 15.06M | 39.50M | 49.85M |
| EV to EBITDA | -7.98 | -1.92 | -0.58 | -1.60 | -2.85 |
| EV to Sales | 0.00 | 42.40 | 0.00 | 19.58 | 12.45 |
| EV to Free Cash Flow | -9.82 | -1.70 | -0.79 | -2.59 | -2.58 |
| EV to Operating Cash Flow | -9.82 | -1.70 | -0.79 | -2.59 | -2.58 |
| Tangible Book Value Per Share | 7.65 | 2.48 | -8.90 | 3.04 | 9.72 |
| Shareholders’ Equity Per Share | 7.65 | 2.11 | -11.84 | -5.59 | -6.22 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | 0.00 | -0.01 | -0.01 |
| Revenue Per Share | 0.00 | 0.18 | 0.00 | 1.05 | 2.56 |
| Net Income Per Share | -3.20 | -3.20 | -9.71 | -9.98 | -8.29 |
| Tax Burden | 0.87 | 0.82 | 0.78 | 0.77 | 0.74 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 11.35 | 0.00 | 6.12 | 3.33 |
| SG&A to Revenue | 0.00 | 13.42 | 0.00 | 6.05 | 3.08 |
| Stock-Based Compensation to Revenue | 0.00 | 2.71 | 0.00 | 0.00 | 0.59 |
| Income Quality | 0.81 | 1.11 | 0.94 | 0.80 | 1.09 |
Currency in USD
